All the time in the world is never enough time. You especially notice this when you don't know if you'll get another day.

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.

PET imaging using a radiolabeled antibody picked up clear cell renal cell carcinoma and could help avert unnecessary biopsies ...

BRCA mutations are inextricably linked with breasts, but they can also lead to cancer in the pancreas, the prostate, and ...

I’d only ever had two days off sick, and that was in my 20s. When the company I worked for invited me to a routine executive ...

Q: Is PSA testing still the best screening test for prostate cancer? A: While middle-age men should consider the pros and ...

Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

Hirst III Professors of Oncology in Pathology and members of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. The scientists found that the absence of a protein called PKCλ/ι in ...

The unassuming yet popular white button mushroom has cancer-fighting abilities, according to the results of a human clinical ...

William Boruett ,86, a Cancer survivor from Eldama Ravine displays his book titled “Cancer is Not a Death Sentence” on ...

Researchers have developed a three-dimensional mathematical model of prostate cancer. The model depicts various processes, including tumour growth, genetic evolution and tumour cell competition.